Bruxism is excessive teeth grinding or jaw clenching. It is an oral parafunctional activity; i.e., it is unrelated to normal function such as eating or talking. Bruxism is a common behavior; reports of prevalence range from 8–31% in the general population. Several symptoms are commonly associated with bruxism, including hypersensitive teeth, aching jaw muscles, headaches, tooth wear, and damage to dental restorations (e.g. crowns and fillings) to teeth. But symptoms may be minimal, without patient awareness of the condition.
Increasing prevalence of sleeping bruxism, rise in pediatric population, and changing lifestyles are factors expected to drive market growth over the forecast period. Availability of therapeutic medicines in the form of antidepressants, muscle relaxants, and others can provide growth opportunities to the market. But high costs of custom-made night guards and lack of treatment options for SB can impede the market.

Market Analysis and Insights: Global Sleeping Bruxism Treatment Market
The global Sleeping Bruxism Treatment market size is projected to reach US$ 599.9 million by 2027, from US$ 460.7 million in 2020, at a CAGR of 3.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sleeping Bruxism Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sleeping Bruxism Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sleeping Bruxism Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sleeping Bruxism Treatment market.

Global Sleeping Bruxism Treatment Scope and Market Size
Sleeping Bruxism Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sleeping Bruxism Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Treatment
Diagnosis

Segment by Application
Hospitals
Dental Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Carestream Dental (US)
Pfizer Inc. (US)
Ipsen Biopharmaceuticals(US)
Henry Schein(US)
PLANMECA OY (Finland)
Patterson Dental Supply(US)
Randmark Dental Products, LLC (US)
Akervall Technologies Inc. (US)
Merz Pharma GmbH & Co. KGaA (Germany)
S4S Dental Laboratory (U.K.)
Ivoclar Vivadent AG (Liechtenstein)